Abstract
Infections are a major complication of solid organ transplants (SOTs). This study aimed to describe recipients’ characteristics, and the frequency and etiology of infections and transplant outcome in liver and lung SOTs, and to investigate exposures associated to infection and death in liver transplant recipients. The study population included recipients of SOTs performed in Italy during a 1-year period in ten Italian lung transplant units and eight liver transplant units. Data on comorbidities, infections, retransplantation, and death were prospectively collected using a web-based system, with a 6-month follow-up. The cumulative incidence of infection was 31.7% and 47.8% in liver and lung transplants, respectively, with most infections occurring within the first month after transplantation. Gram-negatives, which were primarily multidrug-resistant, were the most frequent cause of infection. Death rates were 0.42 per 1000 recipient-days in liver transplants and 1.41 per 1000 recipient-days in lung transplants. Infection after SOT in adult liver recipients is associated to an increased risk of death (OR = 13.25; p-value < 0.001). Given the frequency of infection caused by multidrug-resistant microorganisms in SOT recipients in Italy and the heavy impact of infections on the transplant outcome, the reinforcement of surveillance and control activities to prevent the transmission of multidrug-resistant microorganisms in SOT recipients represents a priority. The implementation of the study protocol in liver and lung transplant units and the sharing of results have increased the awareness about the threat due to antimicrobial resistance in the country.
Similar content being viewed by others
References
Fishman JA (2017) Infection in organ transplantation. Am J Transplant 17(4):856–879. https://doi.org/10.1111/ajt.14208
Fishman JA (2011) Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl 17(Suppl 3):S34–S37. https://doi.org/10.1002/lt.22378
Hamandi B, Husain S, Grootendorst P, Papadimitropoulos EA (2016) Clinical and microbiological epidemiology of early and late infectious complications among solid-organ transplant recipients requiring hospitalization. Transpl Int 29(9):1029–1038. https://doi.org/10.1111/tri.12808
Martins N, Martins IS, de Freitas WV et al (2012) Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii. Transpl Infect Dis 14(3):316–320. https://doi.org/10.1111/j.1399-3062.2011.00701.x
Goldberg E, Bishara J, Lev S, Singer P, Cohen J (2012) Organ transplantation from a donor colonized with a multidrug-resistant organism: a case report. Transpl Infect Dis 14(3):296–299. https://doi.org/10.1111/j.1399-3062.2011.00697.x
Carmeli Y, Akova M, Cornaglia G et al (2010) Controlling the spread of carbapenemase-producing gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 16(2):102–111. https://doi.org/10.1111/j.1469-0691.2009.03115.x
Satlin MJ, Jenkins SG, Walsh TJ (2014) The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis 58(9):1274–1283
European Centre for Disease Prevention and Control (ECDC) (2017) Antimicrobial resistance surveillance in Europe 2015. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC, Stockholm
Magiorakos A-P, Suetens C, Monnet DL, Gagliotti C, Heuer OE; EARS-Net Coordination Group and EARS-Net participants (2013) The rise of carbapenem resistance in Europe: just the tip of the iceberg? Antimicrob Resist Infect Control 2(1):6. https://doi.org/10.1186/2047-2994-2-6
Lanini S, Costa AN, Puro V et al (2015) Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: a nationwide surveillance study. PLoS One 10(4):e0123706
Zhong L, Men TY, Li H et al (2012) Multidrug-resistant gram-negative bacterial infections after liver transplantation - spectrum and risk factors. J Infect 64(3):299–310
Giannella M, Muñoz P, Alarcón JM, Mularoni A, Grossi P, Bouza E; PISOT study group (2014) Pneumonia in solid organ transplant recipients: a prospective multicenter study. Transpl Infect Dis 16(2):232–241. https://doi.org/10.1111/tid.12193
Masiero L, Procaccio F, Vespasiano F et al (2013) Prevenzione della diffusione di infezioni sostenute da microrganismi multiresistenti (MDR) in ambito trapiantologico e analisi del rischio (SINT). Trapianti 17(4):145–151
Charlson ME, Sax FL, MacKenzie CR, Fields SD, Braham RL, Douglas RG Jr (1986) Assessing illness severity: does clinical judgment work? J Chronic Dis 39(6):439–452
Kamath PS, Kim WR (2007) The model for end-stage liver disease (MELD). Hepatology 45(3):797–805
Herati RS, Blumberg EA (2012) Losing ground: multidrug-resistant bacteria in solid-organ transplantation. Curr Opin Infect Dis 25(4):445–449. https://doi.org/10.1097/QCO.0b013e328354f192
Grossi PA (2015) Le infezioni da batteri multiresistenti: quale rischio e quale prevenzione. Trapianti 19(4):143–145
Cervera C, van Delden C, Gavaldà J, Welte T, Akova M, Carratalà J; ESCMID Study Group for Infections in Compromised Hosts (2014) Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect 20(Suppl 7):49–73. https://doi.org/10.1111/1469-0691.12687
van Duin D, van Delden C; AST Infectious Diseases Community of Practice (2013) Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant 13(Suppl 4):31–41. https://doi.org/10.1111/ajt.12096
Len O, Garzoni C, Lumbreras C et al (2014) Recommendations for screening of donor and recipient prior to solid organ transplantation and to minimize transmission of donor-derived infections. Clin Microbiol Infect 20(Suppl 7):10–18. https://doi.org/10.1111/1469-0691.12557
Squier C, Rihs JD, Risa KJ et al (2002) Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 23(9):495–501
Lübbert C, Becker-Rux D, Rodloff AC et al (2014) Colonization of liver transplant recipients with KPC-producing Klebsiella pneumoniae is associated with high infection rates and excess mortality: a case–control analysis. Infection 42(2):309–316. https://doi.org/10.1007/s15010-013-0547-3
Schwaber MJ, Carmeli Y (2013) An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clin Infect Dis 58(5):697–703
Gagliotti C, Ciccarese V, Sarti M et al (2013) Active surveillance for asymptomatic carriers of carbapenemase-producing Klebsiella pneumoniae in a hospital setting. J Hosp Infect 83(4):330–332
Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V; European Network on Carbapenemases (2012) Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 18(5):432–438
Funding
This study was endorsed by the Italian National Transplant Center (CNT) and supported by a grant from the Italian Ministry of Health (CCM 2012) “Prevenzione della diffusione di infezioni sostenute da microrganismi multiresistenti (MDR) in ambito trapiantologico e analisi del rischio” [13].
Author information
Authors and Affiliations
Consortia
Contributions
Carlo Gagliotti: wrote the manuscript. Carlo Gagliotti, Filomena Morsillo, Maria Luisa Moro, Lucia Masiero, Francesco Procaccio, Francesca Vespasiano, Annalisa Pantosti, Monica Monaco, Giulia Errico, Andrea Ricci, Paolo Antonio Grossi, Alessandro Nanni Costa, and the SInT Collaborative Study Group: provided feedback, contributed with comments, and reviewed the manuscript. Carlo Gagliotti, Filomena Morsillo, Maria Luisa Moro, Lucia Masiero, Francesco Procaccio, Francesca Vespasiano, Annalisa Pantosti, Monica Monaco, Giulia Errico, Andrea Ricci, Paolo Antonio Grossi, and Alessandro Nanni Costa: contributed to planning the study and designing the study protocol. Carlo Gagliotti and Filomena Morsillo: performed the data analysis. The SInT Collaborative Study Group: implemented the protocol and provided the study data.
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical approval
The study protocol was approved by the Ethical Committees of the Italian Health Institute (Istituto Superiore di Sanità) and of the participating clinical centers.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Appendix
Appendix
List of the members of the SInT Collaborative Study Group:
Domenico Adorno(25) ; Simone Ambretti(7) ; Antonio Amoroso(20) ; Milena Arghittu(15c) ; Pasquale Berloco(14) ; Alessandro Bertani(16a) ; Manuela Bonizzoli(24) ; Patrizia Cambieri(17c) ; Marco Canzonieri(16) ; Mario Caprio(2) ; Elena Carrara(17a) ; Rosaria Carrinola(13b) ; Eva Cibelli(12b) ; Umberto Cillo(15b ) ; Michele Colledan(11) ; Rosaria Colombo(15c) ; Elena Coluccio(13) ; Pier Giulio Conaldi(16c) ; Mariagrazia Cusi(18) ; Andrea Maria D’Armini(17a) ; Adelaide Da Riva(15b ) ; Bianca D'Auria(14) ; Luciano De Carlis(12b) ; Carlo De Cillia(23) ; Andrea De Gasperi(12 b) ; Antonino Di Caro(6) ; Paola Di Ciaccio(2) ; Daniele Dondossola(13a) ; Claudio Farina(11 c) ; Giuseppe Feltrin(22) ; Alba Carola Finarelli(5) ; Lucina Fossati(19c) ; Paolo Gaibani(7) ; Aurora Garcia Fernandez(3) ; Giovanni Gesu(12c) ; Raffaella Giacometti(20) ; Floriana Gona(16c) ; Bruno Gridelli(16) ; Lucia Henrici De Angelis(18c) ; Maria Paola Landini(7 c) ; Federica Maldarelli(14) ; Carlo Mancini(14c) ; Piero Marone(17c) ; Alessandra Mularoni(16a) ; Giulia Paglialunga(14) ; Piero Paladini(18c) ; Giorgio Palù(8) ; Saverio Parisi(8) ; Adriano Peris(24) ; Antonio Daniele Pinna(10b) ; Marco Platto(11) ; Francesco Pugliese(14) ; Francesca Puoti(2) ; Claudio Rago(22) ; Mario Ravini(12a) ; Federico Rea(15a) ; Mauro Rinaldi(19a) ; Giorgio Rossi(13b) ; Lucia Rossi(8) ; Massimo Rossi(14b) ; Mauro Salizzoni(19b) ; Gabriela Sangiorgi(23) ; Luigi Santambrogio(13a) ; Marco Spada(16b) ; Vito Sparacino(26) ; Franco Stella(10a) ; Rosanna Torelli(21) ; Erminio Torresani(13c) ; Davide Tosi(13a) ; Francesca Vailati(11c) ; Maurizio Valeri(25) ; Federico Venuta(14a) ; Sergio Vesconi(21) ; Pierluigi Viale(9) ; Chiara Vismara(12c).
Study Coordinators:
1 Agenzia Sanitaria e Sociale Regionale Emilia-Romagna, Bologna
2 Centro Nazionale Trapianti, Istituto Superiore di Sanità, Roma
3 Dipartimento di Malattie Infettive, Istituto Superiore di Sanità, Roma
4 Clinica delle Malattie Infettive e Tropicali, Università degli studi dell’Insubria, Varese
5 Assessorato Politiche per la Salute RER, Direzione Generale Sanità e Politiche Sociali - Servizio Sanità Pubblica, Bologna
6 Istituto Nazionale per le Malattie Infettive “L.Spallanzani” IRCCS, Roma
7 Microbiologia, Policlinico Sant’Orsola Malpighi, Bologna
8 Dipartimento di Istologia, Microbiologia e Biotecnologie Mediche, Azienda Ospedaliera –Università, Padova
9 Unità Operativa Malattie Infettive, Policlinico Sant’Orsola Malpighi, Bologna
Participating Hospitals: Lung & Liver Transplant Units, Microbiological Laboratories
10 Policlinico Sant’Orsola Malpighi, Bologna
11 A.S.S.T. Giovanni XXIII, Bergamo
12 Grande Ospedale Metropolitano, ASST Niguarda, Milano
13 I.R.C.C.S. Fondazione Ospedale Maggiore Policlinico, Milano
14 Policlinico Umberto I, Roma
15 Azienda Ospedaliera – Università, Padova
16 I.R.C.C.S. ISMETT, Palermo
17 I.R.C.C.S. Policlinico SAN Matteo, Pavia
18 Azienda Ospedaliera Universitaria, Siena
19 Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino - Presidio Molinette
(a = Lung Transplant Unit; b = Liver Transplant Unit; c = Microbiological Laboratory)
Regional Transplant Centers:
20 Centro Regionale Trapianti, Regione Piemonte, Torino
21 Centro Regionale Trapianti Regione Lombardia, Milano
22 Centro Regionale Trapianti Regione Veneto, Padova
23 Centro Regionale Trapianti Regione Emilia Romagna, Bologna
24 Centro Regionale Trapianti Regione Toscana, Firenze
25 Centro Regionale Trapianti Regione Lazio, Roma
26 Centro Regionale Trapianti Regione Sicilia, Palermo
Rights and permissions
About this article
Cite this article
Gagliotti, C., Morsillo, F., Moro, M.L. et al. Infections in liver and lung transplant recipients: a national prospective cohort. Eur J Clin Microbiol Infect Dis 37, 399–407 (2018). https://doi.org/10.1007/s10096-018-3183-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-018-3183-0